Global Temozolomide for Injection Market Growth 2025-2031

Product Code: 1704796

Industry: Pharma & Healthcare

Published: Jul 11,2025

Pages: 93

Delivery Time: 2-3 business days

Global Temozolomide for Injection Market Growth 2025-2031

Product Code: 1704796

Industry: Pharma & Healthcare

Published: Jul 11,2025

Pages: 93

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Temozolomide for Injection market size is predicted to grow from US$ 13.8 million in 2025 to US$ 16.2 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Temozolomide for Injection is an alkylating antineoplastic agent indicated for the treatment of certain types of brain tumors, such as glioblastoma multiforme (GBM) and anaplastic astrocytoma, particularly in patients who are unable to tolerate oral therapy or have impaired gastrointestinal function. As a DNA-alkylating agent, it exerts its anticancer effect by damaging the DNA of rapidly dividing tumor cells, thereby inhibiting their replication. The injectable formulation offers an alternative route for precise dosing and is especially valuable for hospitalized patients experiencing severe nausea, vomiting, or difficulty swallowing. It is commonly used in concurrent chemoradiotherapy or in recurrence settings.

United States market for Temozolomide for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Temozolomide for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Temozolomide for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Temozolomide for Injection players cover Merck, Jodas Expoim, Jiangsu Tasly Diyi Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Shanghai Huilun Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Temozolomide for Injection Industry Forecast” looks at past sales and reviews total world Temozolomide for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Temozolomide for Injection sales for 2025 through 2031. With Temozolomide for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Temozolomide for Injection industry.

This Insight Report provides a comprehensive analysis of the global Temozolomide for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Temozolomide for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Temozolomide for Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Temozolomide for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Temozolomide for Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Temozolomide for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Original Drug
    Generic Drug

Segmentation by Application:
    Hospital
    Clinic
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Merck
    Jodas Expoim
    Jiangsu Tasly Diyi Pharmaceutical
    Jiangsu Aosaikang Pharmaceutical
    Shanghai Huilun Pharmaceutical
    Jiangsu Hengrui Pharmaceuticals

Key Questions Addressed in this Report
What is the 10-year outlook for the global Temozolomide for Injection market?
What factors are driving Temozolomide for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Temozolomide for Injection market opportunities vary by end market size?
How does Temozolomide for Injection break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Temozolomide for Injection Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Temozolomide for Injection by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Temozolomide for Injection by Country/Region, 2020, 2024 & 2031
    2.2 Temozolomide for Injection Segment by Type
        2.2.1 Original Drug
        2.2.2 Generic Drug
    2.3 Temozolomide for Injection Sales by Type
        2.3.1 Global Temozolomide for Injection Sales Market Share by Type (2020-2025)
        2.3.2 Global Temozolomide for Injection Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Temozolomide for Injection Sale Price by Type (2020-2025)
    2.4 Temozolomide for Injection Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Others
    2.5 Temozolomide for Injection Sales by Application
        2.5.1 Global Temozolomide for Injection Sale Market Share by Application (2020-2025)
        2.5.2 Global Temozolomide for Injection Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Temozolomide for Injection Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Temozolomide for Injection Breakdown Data by Company
        3.1.1 Global Temozolomide for Injection Annual Sales by Company (2020-2025)
        3.1.2 Global Temozolomide for Injection Sales Market Share by Company (2020-2025)
    3.2 Global Temozolomide for Injection Annual Revenue by Company (2020-2025)
        3.2.1 Global Temozolomide for Injection Revenue by Company (2020-2025)
        3.2.2 Global Temozolomide for Injection Revenue Market Share by Company (2020-2025)
    3.3 Global Temozolomide for Injection Sale Price by Company
    3.4 Key Manufacturers Temozolomide for Injection Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Temozolomide for Injection Product Location Distribution
        3.4.2 Players Temozolomide for Injection Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Temozolomide for Injection by Geographic Region
    4.1 World Historic Temozolomide for Injection Market Size by Geographic Region (2020-2025)
        4.1.1 Global Temozolomide for Injection Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Temozolomide for Injection Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Temozolomide for Injection Market Size by Country/Region (2020-2025)
        4.2.1 Global Temozolomide for Injection Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Temozolomide for Injection Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Temozolomide for Injection Sales Growth
    4.4 APAC Temozolomide for Injection Sales Growth
    4.5 Europe Temozolomide for Injection Sales Growth
    4.6 Middle East & Africa Temozolomide for Injection Sales Growth

5 Americas
    5.1 Americas Temozolomide for Injection Sales by Country
        5.1.1 Americas Temozolomide for Injection Sales by Country (2020-2025)
        5.1.2 Americas Temozolomide for Injection Revenue by Country (2020-2025)
    5.2 Americas Temozolomide for Injection Sales by Type (2020-2025)
    5.3 Americas Temozolomide for Injection Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Temozolomide for Injection Sales by Region
        6.1.1 APAC Temozolomide for Injection Sales by Region (2020-2025)
        6.1.2 APAC Temozolomide for Injection Revenue by Region (2020-2025)
    6.2 APAC Temozolomide for Injection Sales by Type (2020-2025)
    6.3 APAC Temozolomide for Injection Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Temozolomide for Injection by Country
        7.1.1 Europe Temozolomide for Injection Sales by Country (2020-2025)
        7.1.2 Europe Temozolomide for Injection Revenue by Country (2020-2025)
    7.2 Europe Temozolomide for Injection Sales by Type (2020-2025)
    7.3 Europe Temozolomide for Injection Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Temozolomide for Injection by Country
        8.1.1 Middle East & Africa Temozolomide for Injection Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Temozolomide for Injection Revenue by Country (2020-2025)
    8.2 Middle East & Africa Temozolomide for Injection Sales by Type (2020-2025)
    8.3 Middle East & Africa Temozolomide for Injection Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Temozolomide for Injection
    10.3 Manufacturing Process Analysis of Temozolomide for Injection
    10.4 Industry Chain Structure of Temozolomide for Injection

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Temozolomide for Injection Distributors
    11.3 Temozolomide for Injection Customer

12 World Forecast Review for Temozolomide for Injection by Geographic Region
    12.1 Global Temozolomide for Injection Market Size Forecast by Region
        12.1.1 Global Temozolomide for Injection Forecast by Region (2026-2031)
        12.1.2 Global Temozolomide for Injection Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Temozolomide for Injection Forecast by Type (2026-2031)
    12.7 Global Temozolomide for Injection Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck Temozolomide for Injection Product Portfolios and Specifications
        13.1.3 Merck Temozolomide for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Jodas Expoim
        13.2.1 Jodas Expoim Company Information
        13.2.2 Jodas Expoim Temozolomide for Injection Product Portfolios and Specifications
        13.2.3 Jodas Expoim Temozolomide for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Jodas Expoim Main Business Overview
        13.2.5 Jodas Expoim Latest Developments
    13.3 Jiangsu Tasly Diyi Pharmaceutical
        13.3.1 Jiangsu Tasly Diyi Pharmaceutical Company Information
        13.3.2 Jiangsu Tasly Diyi Pharmaceutical Temozolomide for Injection Product Portfolios and Specifications
        13.3.3 Jiangsu Tasly Diyi Pharmaceutical Temozolomide for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Jiangsu Tasly Diyi Pharmaceutical Main Business Overview
        13.3.5 Jiangsu Tasly Diyi Pharmaceutical Latest Developments
    13.4 Jiangsu Aosaikang Pharmaceutical
        13.4.1 Jiangsu Aosaikang Pharmaceutical Company Information
        13.4.2 Jiangsu Aosaikang Pharmaceutical Temozolomide for Injection Product Portfolios and Specifications
        13.4.3 Jiangsu Aosaikang Pharmaceutical Temozolomide for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
        13.4.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
    13.5 Shanghai Huilun Pharmaceutical
        13.5.1 Shanghai Huilun Pharmaceutical Company Information
        13.5.2 Shanghai Huilun Pharmaceutical Temozolomide for Injection Product Portfolios and Specifications
        13.5.3 Shanghai Huilun Pharmaceutical Temozolomide for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Shanghai Huilun Pharmaceutical Main Business Overview
        13.5.5 Shanghai Huilun Pharmaceutical Latest Developments
    13.6 Jiangsu Hengrui Pharmaceuticals
        13.6.1 Jiangsu Hengrui Pharmaceuticals Company Information
        13.6.2 Jiangsu Hengrui Pharmaceuticals Temozolomide for Injection Product Portfolios and Specifications
        13.6.3 Jiangsu Hengrui Pharmaceuticals Temozolomide for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
        13.6.5 Jiangsu Hengrui Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Temozolomide for Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Temozolomide for Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Original Drug
 Table 4. Major Players of Generic Drug
 Table 5. Global Temozolomide for Injection Sales by Type (2020-2025) & (K Units)
 Table 6. Global Temozolomide for Injection Sales Market Share by Type (2020-2025)
 Table 7. Global Temozolomide for Injection Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Temozolomide for Injection Revenue Market Share by Type (2020-2025)
 Table 9. Global Temozolomide for Injection Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Temozolomide for Injection Sale by Application (2020-2025) & (K Units)
 Table 11. Global Temozolomide for Injection Sale Market Share by Application (2020-2025)
 Table 12. Global Temozolomide for Injection Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Temozolomide for Injection Revenue Market Share by Application (2020-2025)
 Table 14. Global Temozolomide for Injection Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Temozolomide for Injection Sales by Company (2020-2025) & (K Units)
 Table 16. Global Temozolomide for Injection Sales Market Share by Company (2020-2025)
 Table 17. Global Temozolomide for Injection Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Temozolomide for Injection Revenue Market Share by Company (2020-2025)
 Table 19. Global Temozolomide for Injection Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Temozolomide for Injection Producing Area Distribution and Sales Area
 Table 21. Players Temozolomide for Injection Products Offered
 Table 22. Temozolomide for Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Temozolomide for Injection Sales by Geographic Region (2020-2025) & (K Units)
 Table 26. Global Temozolomide for Injection Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Temozolomide for Injection Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Temozolomide for Injection Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Temozolomide for Injection Sales by Country/Region (2020-2025) & (K Units)
 Table 30. Global Temozolomide for Injection Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Temozolomide for Injection Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Temozolomide for Injection Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Temozolomide for Injection Sales by Country (2020-2025) & (K Units)
 Table 34. Americas Temozolomide for Injection Sales Market Share by Country (2020-2025)
 Table 35. Americas Temozolomide for Injection Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Temozolomide for Injection Sales by Type (2020-2025) & (K Units)
 Table 37. Americas Temozolomide for Injection Sales by Application (2020-2025) & (K Units)
 Table 38. APAC Temozolomide for Injection Sales by Region (2020-2025) & (K Units)
 Table 39. APAC Temozolomide for Injection Sales Market Share by Region (2020-2025)
 Table 40. APAC Temozolomide for Injection Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Temozolomide for Injection Sales by Type (2020-2025) & (K Units)
 Table 42. APAC Temozolomide for Injection Sales by Application (2020-2025) & (K Units)
 Table 43. Europe Temozolomide for Injection Sales by Country (2020-2025) & (K Units)
 Table 44. Europe Temozolomide for Injection Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Temozolomide for Injection Sales by Type (2020-2025) & (K Units)
 Table 46. Europe Temozolomide for Injection Sales by Application (2020-2025) & (K Units)
 Table 47. Middle East & Africa Temozolomide for Injection Sales by Country (2020-2025) & (K Units)
 Table 48. Middle East & Africa Temozolomide for Injection Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Temozolomide for Injection Sales by Type (2020-2025) & (K Units)
 Table 50. Middle East & Africa Temozolomide for Injection Sales by Application (2020-2025) & (K Units)
 Table 51. Key Market Drivers & Growth Opportunities of Temozolomide for Injection
 Table 52. Key Market Challenges & Risks of Temozolomide for Injection
 Table 53. Key Industry Trends of Temozolomide for Injection
 Table 54. Temozolomide for Injection Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Temozolomide for Injection Distributors List
 Table 57. Temozolomide for Injection Customer List
 Table 58. Global Temozolomide for Injection Sales Forecast by Region (2026-2031) & (K Units)
 Table 59. Global Temozolomide for Injection Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Temozolomide for Injection Sales Forecast by Country (2026-2031) & (K Units)
 Table 61. Americas Temozolomide for Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Temozolomide for Injection Sales Forecast by Region (2026-2031) & (K Units)
 Table 63. APAC Temozolomide for Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Temozolomide for Injection Sales Forecast by Country (2026-2031) & (K Units)
 Table 65. Europe Temozolomide for Injection Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Temozolomide for Injection Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Middle East & Africa Temozolomide for Injection Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Temozolomide for Injection Sales Forecast by Type (2026-2031) & (K Units)
 Table 69. Global Temozolomide for Injection Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Temozolomide for Injection Sales Forecast by Application (2026-2031) & (K Units)
 Table 71. Global Temozolomide for Injection Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Merck Basic Information, Temozolomide for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 73. Merck Temozolomide for Injection Product Portfolios and Specifications
 Table 74. Merck Temozolomide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Merck Main Business
 Table 76. Merck Latest Developments
 Table 77. Jodas Expoim Basic Information, Temozolomide for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 78. Jodas Expoim Temozolomide for Injection Product Portfolios and Specifications
 Table 79. Jodas Expoim Temozolomide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Jodas Expoim Main Business
 Table 81. Jodas Expoim Latest Developments
 Table 82. Jiangsu Tasly Diyi Pharmaceutical Basic Information, Temozolomide for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 83. Jiangsu Tasly Diyi Pharmaceutical Temozolomide for Injection Product Portfolios and Specifications
 Table 84. Jiangsu Tasly Diyi Pharmaceutical Temozolomide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Jiangsu Tasly Diyi Pharmaceutical Main Business
 Table 86. Jiangsu Tasly Diyi Pharmaceutical Latest Developments
 Table 87. Jiangsu Aosaikang Pharmaceutical Basic Information, Temozolomide for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 88. Jiangsu Aosaikang Pharmaceutical Temozolomide for Injection Product Portfolios and Specifications
 Table 89. Jiangsu Aosaikang Pharmaceutical Temozolomide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Jiangsu Aosaikang Pharmaceutical Main Business
 Table 91. Jiangsu Aosaikang Pharmaceutical Latest Developments
 Table 92. Shanghai Huilun Pharmaceutical Basic Information, Temozolomide for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 93. Shanghai Huilun Pharmaceutical Temozolomide for Injection Product Portfolios and Specifications
 Table 94. Shanghai Huilun Pharmaceutical Temozolomide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Shanghai Huilun Pharmaceutical Main Business
 Table 96. Shanghai Huilun Pharmaceutical Latest Developments
 Table 97. Jiangsu Hengrui Pharmaceuticals Basic Information, Temozolomide for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 98. Jiangsu Hengrui Pharmaceuticals Temozolomide for Injection Product Portfolios and Specifications
 Table 99. Jiangsu Hengrui Pharmaceuticals Temozolomide for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Jiangsu Hengrui Pharmaceuticals Main Business
 Table 101. Jiangsu Hengrui Pharmaceuticals Latest Developments


List of Figures
 Figure 1. Picture of Temozolomide for Injection
 Figure 2. Temozolomide for Injection Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Temozolomide for Injection Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Temozolomide for Injection Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Temozolomide for Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Temozolomide for Injection Sales Market Share by Country/Region (2024)
 Figure 10. Temozolomide for Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Original Drug
 Figure 12. Product Picture of Generic Drug
 Figure 13. Global Temozolomide for Injection Sales Market Share by Type in 2025
 Figure 14. Global Temozolomide for Injection Revenue Market Share by Type (2020-2025)
 Figure 15. Temozolomide for Injection Consumed in Hospital
 Figure 16. Global Temozolomide for Injection Market: Hospital (2020-2025) & (K Units)
 Figure 17. Temozolomide for Injection Consumed in Clinic
 Figure 18. Global Temozolomide for Injection Market: Clinic (2020-2025) & (K Units)
 Figure 19. Temozolomide for Injection Consumed in Others
 Figure 20. Global Temozolomide for Injection Market: Others (2020-2025) & (K Units)
 Figure 21. Global Temozolomide for Injection Sale Market Share by Application (2024)
 Figure 22. Global Temozolomide for Injection Revenue Market Share by Application in 2025
 Figure 23. Temozolomide for Injection Sales by Company in 2025 (K Units)
 Figure 24. Global Temozolomide for Injection Sales Market Share by Company in 2025
 Figure 25. Temozolomide for Injection Revenue by Company in 2025 ($ millions)
 Figure 26. Global Temozolomide for Injection Revenue Market Share by Company in 2025
 Figure 27. Global Temozolomide for Injection Sales Market Share by Geographic Region (2020-2025)
 Figure 28. Global Temozolomide for Injection Revenue Market Share by Geographic Region in 2025
 Figure 29. Americas Temozolomide for Injection Sales 2020-2025 (K Units)
 Figure 30. Americas Temozolomide for Injection Revenue 2020-2025 ($ millions)
 Figure 31. APAC Temozolomide for Injection Sales 2020-2025 (K Units)
 Figure 32. APAC Temozolomide for Injection Revenue 2020-2025 ($ millions)
 Figure 33. Europe Temozolomide for Injection Sales 2020-2025 (K Units)
 Figure 34. Europe Temozolomide for Injection Revenue 2020-2025 ($ millions)
 Figure 35. Middle East & Africa Temozolomide for Injection Sales 2020-2025 (K Units)
 Figure 36. Middle East & Africa Temozolomide for Injection Revenue 2020-2025 ($ millions)
 Figure 37. Americas Temozolomide for Injection Sales Market Share by Country in 2025
 Figure 38. Americas Temozolomide for Injection Revenue Market Share by Country (2020-2025)
 Figure 39. Americas Temozolomide for Injection Sales Market Share by Type (2020-2025)
 Figure 40. Americas Temozolomide for Injection Sales Market Share by Application (2020-2025)
 Figure 41. United States Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 42. Canada Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 43. Mexico Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 44. Brazil Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 45. APAC Temozolomide for Injection Sales Market Share by Region in 2025
 Figure 46. APAC Temozolomide for Injection Revenue Market Share by Region (2020-2025)
 Figure 47. APAC Temozolomide for Injection Sales Market Share by Type (2020-2025)
 Figure 48. APAC Temozolomide for Injection Sales Market Share by Application (2020-2025)
 Figure 49. China Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 50. Japan Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 51. South Korea Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 52. Southeast Asia Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 53. India Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 54. Australia Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 55. China Taiwan Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 56. Europe Temozolomide for Injection Sales Market Share by Country in 2025
 Figure 57. Europe Temozolomide for Injection Revenue Market Share by Country (2020-2025)
 Figure 58. Europe Temozolomide for Injection Sales Market Share by Type (2020-2025)
 Figure 59. Europe Temozolomide for Injection Sales Market Share by Application (2020-2025)
 Figure 60. Germany Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 61. France Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 62. UK Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 63. Italy Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 64. Russia Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 65. Middle East & Africa Temozolomide for Injection Sales Market Share by Country (2020-2025)
 Figure 66. Middle East & Africa Temozolomide for Injection Sales Market Share by Type (2020-2025)
 Figure 67. Middle East & Africa Temozolomide for Injection Sales Market Share by Application (2020-2025)
 Figure 68. Egypt Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 69. South Africa Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 70. Israel Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 71. Turkey Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 72. GCC Countries Temozolomide for Injection Revenue Growth 2020-2025 ($ millions)
 Figure 73. Manufacturing Cost Structure Analysis of Temozolomide for Injection in 2025
 Figure 74. Manufacturing Process Analysis of Temozolomide for Injection
 Figure 75. Industry Chain Structure of Temozolomide for Injection
 Figure 76. Channels of Distribution
 Figure 77. Global Temozolomide for Injection Sales Market Forecast by Region (2026-2031)
 Figure 78. Global Temozolomide for Injection Revenue Market Share Forecast by Region (2026-2031)
 Figure 79. Global Temozolomide for Injection Sales Market Share Forecast by Type (2026-2031)
 Figure 80. Global Temozolomide for Injection Revenue Market Share Forecast by Type (2026-2031)
 Figure 81. Global Temozolomide for Injection Sales Market Share Forecast by Application (2026-2031)
 Figure 82. Global Temozolomide for Injection Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Merck

Jodas Expoim

Jiangsu Tasly Diyi Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Shanghai Huilun Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff